Skip to main content
. 2022 Jun 11;38(1):119–128. doi: 10.1093/ndt/gfac197

Table 1.

Reclassification across eGFR categories with the 2021 CKD-EPI equation from eGFR categories with the 2009 CKD-EPI equation

eGFR category
with the 2009
equation, mL/min/ eGFR category with the 2021 equation, mL/min/1.73 m2
1.73 m2 ≥90 60–89 45–59 30–44 15–29 <15 Total
≥90 1036982 (100%) 1036982 (64.8%)
60–89 129363 (26.8%) 353218 (73.2%) 482581 (30.1%)
45–59 20912 (39.0%) 32712 (61.0%) 53624 (3.3%)
30–44 6716 (33.1%) 13559 (66.9%) 20275 (1.3%)
15–29 1709 (27.0%) 4623 (73.0%) 6332 (0.4%)
<15 244 (16.9%) 1199 (83.1%) 1443 (0.1%)
Total 1166345 (72.8%) 374130 (23.4%) 39428 (2.5%) 15268 (1.0%) 4867 (0.3%) 1199 (0.1%) 1601237

Data in blue cells are the number of participants who are reclassified to less severe CKD G categories, and percentages represent the proportion of participants in the eGFR category with the 2009 equation that are reclassified to a higher eGFR category with the 2021 equation. The percentages in parentheses in the ‘Total’ row and column denote the proportion of participants in each eGFR category. Total number of participants reclassified = 158944 (9.9% of total population). Total number of participants with CKD G3a–G5 reclassified = 29581 (36.2% of CKD G3a–G5 population).